Capital Fund Management (CFM)’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $25.6M | Buy |
203,628
+27,987
| +16% | +$3.52M | 0.07% | 81 |
|
2025
Q1 | $19.4M | Buy |
175,641
+71,117
| +68% | +$7.87M | 0.06% | 107 |
|
2024
Q4 | $14.3M | Sell |
104,524
-7,048
| -6% | -$962K | 0.04% | 202 |
|
2024
Q3 | $12.9M | Buy |
111,572
+54,621
| +96% | +$6.29M | 0.04% | 188 |
|
2024
Q2 | $7.84M | Buy |
+56,951
| New | +$7.84M | 0.02% | 245 |
|
2021
Q2 | – | Sell |
-60,266
| Closed | -$5.86M | – | 782 |
|
2021
Q1 | $5.86M | Buy |
60,266
+40,409
| +204% | +$3.93M | 0.06% | 141 |
|
2020
Q4 | $1.9M | Sell |
19,857
-2,810
| -12% | -$269K | 0.02% | 296 |
|
2020
Q3 | $2.18M | Buy |
22,667
+3,329
| +17% | +$320K | 0.03% | 258 |
|
2020
Q2 | $2.36M | Sell |
19,338
-4,305
| -18% | -$525K | 0.04% | 178 |
|
2020
Q1 | $2.05M | Buy |
+23,643
| New | +$2.05M | 0.03% | 262 |
|
2019
Q4 | – | Hold |
0
| – | – | – | 1056 |
|
2019
Q3 | – | Sell |
-6,932
| Closed | -$585K | – | 947 |
|
2019
Q2 | $585K | Buy |
6,932
+3,612
| +109% | +$305K | 0.01% | 505 |
|
2019
Q1 | $292K | Sell |
3,320
-21,712
| -87% | -$1.91M | ﹤0.01% | 671 |
|
2018
Q4 | $1.79M | Buy |
25,032
+13,732
| +122% | +$981K | 0.02% | 391 |
|
2018
Q3 | $1.39M | Buy |
+11,300
| New | +$1.39M | 0.01% | 530 |
|
2018
Q2 | – | Hold |
0
| – | – | – | 1137 |
|
2018
Q1 | – | Hold |
0
| – | – | – | 1092 |
|
2017
Q2 | – | Sell |
-146,598
| Closed | -$6.35M | – | 971 |
|
2017
Q1 | $6.35M | Buy |
146,598
+117,886
| +411% | +$5.1M | 0.05% | 222 |
|
2016
Q4 | $1.11M | Buy |
28,712
+15,760
| +122% | +$610K | 0.01% | 534 |
|
2016
Q3 | $656K | Sell |
12,952
-64,169
| -83% | -$3.25M | 0.01% | 602 |
|
2016
Q2 | $3.51M | Buy |
77,121
+68,711
| +817% | +$3.12M | 0.03% | 305 |
|
2016
Q1 | $333K | Sell |
8,410
-84,126
| -91% | -$3.33M | ﹤0.01% | 720 |
|
2015
Q4 | $5.24M | Sell |
92,536
-217,173
| -70% | -$12.3M | 0.05% | 236 |
|
2015
Q3 | $12.3M | Buy |
309,709
+238,342
| +334% | +$9.48M | 0.14% | 104 |
|
2015
Q2 | $3.41M | Buy |
+71,367
| New | +$3.41M | 0.04% | 236 |
|